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Intensive care management of varicella pneumonia 
P. D. POTGIETER AND J. M. J. HAMMOND” 
Respiratory Intensive Care Unit, Department of Anaesthesia and Medicine, Groote Schuuv 
Hospital, Cape Town, South Africa 
To determine the clinical features, treatment and outcome of severe varicella pneumonia with hypoxic 
respiratory failure requiring intensive care management, a prospective survey of consecutive cases was 
undertaken. Fifteen consecutive adult cases of varicella pneumonia with respiratory failure admitted to 
a lo-bed respiratory intensive care unit over a period of 10 y from 1984-1993 were studied. All patients 
were given acyclovir immediately on admission. The level of ventilatory support needed was determined 
by the severity of gas exchange abnormality, and varied from face mask oxygen (three patients), through 
continuous positive airway pressure (CPAP) by face mask (eight patients), to continuous positive 
pressure ventilation (CPPV) (four patients). !. 
The majority of patients were young females, only one of &horn was pregnant. All patients had been 
in close contact with a known case of chickenpox. All patients responded well to acyclovir and 
ventilatory support with improved oxygenation. Monitoring with pulse oximetry was important to detect 
episodes of desaturation on inadvertent discontinuation of positive and expiratory pressure (PEEP). Two 
patients were admitted with bacterial superinfection, and one patient, who had required intubation and 
CPPV, developed nosocomial respiratory tract infection. There were no deaths. 
This experience suggests that intensive care admission, with the early administration of intravenous 
acyclovir and recognition of the severity of the hypoxaemia resulting from varicella pneumonia (which 
can be reversed with PEEP), should reduce the mortality of severe varicella pneumonia in adults. 
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Introduction 
Chickenpox (varicella), which is usually a mild 
disease of childhood, may cause a severe 
pneumonia in adults. A few cases of varicella 
pneumonia are reported but the true incidence of 
pneumonia complicating chickenpox in adults is 
unknown (1). In 114 patients with chickenpox 
infection, all of whom underwent radiological 
investigation in a military institution, the inci- 
dence of abnormality suggesting pneumonia on 
the chest radiography was 16.3%; clinical 
pneumonia was diagnosed in 13 of 93 hospital- 
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ized adult patients in a study from Hungary, 
and in a series of 253 cases in the U.S.A., 34% 
were diagnosed as having pneumonia (2-4). In 
Stockholm, over a lO-yr period until 1989, the 
incidence of varicella pneumonitis requiring 
hospitalization ranged from 0.1-0.5 per 100 000 
per yr (5). 
Varicella pneumonia has a reported mortality 
of between 10 and 20% in the general popula- 
tion, but in pregnancy it may be as high as 41%, 
although recent studies report a mortality of 
only 10 and 11% for non-pregnant and pregnant 
patients, respectively (2;6-8). 
Anti-viral agents (particularly acyclovir) are 
reported to have little influence on mortality in 
severe varicella pneumonia in adults; however, 
this is based largely on anecdotal reports and 
has not been adequately evaluated (5,7). In one 
of the earliest cases of pneumonia treated with 
acyclovir, the virus was cleared from the vesicles 
within 24 h, and cropping of vesicles ceased 
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almost immediately on commencing acyclovir 
(9). This could be expected to result in more 
rapid resolution and reduce the period required 
for respiratory support with its consequent 
complications. In a recent report of 13 cases, 
acyclovir was thought to be of value in those 
with hypoxaemia, and a current review of its use 
in pregnancy suggests a reduced mortality (1,lO). 
Reasons advanced for lack of efficacy of acyclo- 
vir in some reports is delay in treatment or the 
development of secondary bacterial infection (7). 
This prospective, descriptive case survey 
reports the clinical presentation and successful 
management of 15 cases of varicella pneumonia 
with respiratory failure admitted to the.>author’s 
respiratory intensive care unit in a 1500-bed, 
tertiary teaching hospital over a period of 10 yr 
from 1984 to 1993. 
Patients and Methods 
The 15 adult cases, who had a clinical diagnosis 
of varicella, and radiological and clinical fea- 
tures of pneumonia, represented 3.5% of patients 
with community-acquired pneumonia treated in 
the intensive care unit (ICU) over the lo-yr 
time period. All patients were in respiratory 
failure with hypoxaemia, and required ventila- 
tory support either with face mask oxygen, 
continuous positive airway pressure (CPAP) by 
face mask or intermittent positive pressure 
ventilation with positive end expiratory pressure 
(PEEP) (CPPV). Indication for face mask CPAP 
was persistent hypoxaemia (PaO, ~60 mmHg), 
despite 40% oxygen by mask, adequate alveolar 
ventilation (PaCO, ~42 mmHg), and a patient 
who was fully co-operative with an effective 
cough capable of protecting the airway. Failure 
to meet the above criteria for adequate respir- 
atory function, despite CPAP, was an indication 
for immediate intubation and CPPV. A free- 
flow design CPAP apparatus with an oxygen 
blender and heated humidification was used 
for CPAP (Cape CPAP system), and patients 
requiring CPPV were ventilated using constant 
volume ventilators (Bear 2 or 2e) with a heated 
humidifier (Fisher-Paykel). 
Patients were fed a normal diet enterally as 
soon as possible or by enteral tube feeds with 
the majority receiving 1000-1500 kcals day- ‘. 
No prophylaxis was used for stress ulceration. 
Continuous electrocardiogram (EKG) and 
oxygen saturation were monitored, and pulse 
rate, respiratory rate, blood pressure and tem- 
perature were recorded every 2 h by nursing 
personnel. 
Patient demographic data were recorded, and 
the severity of illness was calculated using the 
APACHE II scoring system, with the worst 
physiological parameters in the first 24 h after 
admission being used (11). All associated dis- 
eases and compromising factors present on 
admission were recorded. The duration of ven- 
tilation, indications for different ventilatory 
modalities, and complications were documented. 
A special note of all procedures with their com- 
plications, and all other complications were 
recorded. Drug therapy was also documented. 
All information was collected during the 
patients’ stay in the ICU by the investigators or 
a deputy, and stored on a database program 
(D Base-IV, Ashton-Tate, Mountain View, CA, 
U.S.A.), designed for this ICU information. 
Analysis was performed using the statistical pro- 
gram ‘Statcalc’ of Epi-Info (Version 5) (U.S. 
Department of Health and Human Sciences/ 
Public Health Service/Center for Disease 
Control U.S.A.). Numerical data is reported as 
mean and standard deviation. Comparison 
between data was done by Student’s t-test for 
nominal data, and Chi-square testing for 
categorical variables where appropriate. 
Results 
The diagnosis was clinically obvious in all 
patients with a history of exposure, a febrile 
illness (mean temperature 38.5 i 0.96”C), and a 
typical, generalized vesicular rash, which usually 
also involved the oropharyngeal and buccal 
mucosal surfaces. In three cases, the rash was 
not typical on presentation, thus delaying diag- 
nosis. The patients were all sick and toxic with 
marked respiratory distress and hypoxaemia on 
admission. The mean respiratory rate was 
37.7 f 9.44 breaths min- ‘, and the mean ratio 
of PaO, mmHg to AO, was 216 f 99.2. All 
patients had a typical, diffuse nodular infiltrate 
on the chest radiograph; however, in some, in 
addition to the interstitial infiltrate, areas of 
confluent opacification were also present. The 
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radiographs had resolved completely at hospital 
discharge with no calcification; however, no 
long-term X-rays were examined systematically. 
In three cases, the diagnosis was confirmed with 
serology. The presenting clinical features are 
shown in Table 1. The serum urea, creatinine 
and bilirubin were normal in all cases; mean 
serum albumin was 34.1 f 3.4 g I- i; mean 
serum sodium was 132.2 f 2.91 mmol 1 - ‘; and 
the liver enzymes were all elevated with a mean 
alanine transferase (ALT) of 49.7 i 27 units 1 - i, 
aspartine transferase (AST) 67.7 f 42 units I- i 
and lactate dehydrogenase (LDH) 811 f 23 1 
units 1 - ‘. 
No patients had a previous history of chicken- 
pox. Nine were young females who all had had 
direct exposure to chickenpox. Only one was 
pregnant, and the other eight had no underlying 
disease. The two elderly, male patients had 
also been directly exposed to grandchildren with 
chickenpox. Only one patient was immuno- 
compromised, a 16-year-old boy with Hodgkin’s 
disease, and he too had no history of previous 
chickenpox. No patients were suspected of 
having human immunodeficiency virus (HIV) 
infection, and routine serological investigation 
was not performed. The average age was 
27.3 f 12.12 years, and the duration of ICU 
admission was 6.07 * 1.91 days. The demo- 
graphics and severity of illness, ventilatory 
therapy, and duration of ICU admission are 
shown in Table 1. The clinical features in Table I 
represent the findings on admission to the ICU. 
Most patients were admitted directly from the 
emergency room. 
All patients were treated immediately on diag- 
nosis with intravenous acyclovir 250-500 mg 
every 8 h for 2-3 days, then orally for a total of 
5 days. Two patients were admitted with recog- 
nized bacterial superinfection: one patient had 
bronchial infection with Haemophilus influenzae 
considered significant on Gram’s stain and cul- 
ture of tracheal aspirate; and the other, the 
patient with Hodgkin’s disease, had extensive 
bronchopneumonia with H. inzuenzae present 
on Gram’s stain and culture of sputum. Only 
those patients who were thought to have a 
bacterial infection on both clinical and bacterio- 
logical criteria, were given broad-spectrum anti- 
microbial therapy (including anti-staphylococcal 
agents). 
Four patients, including the two elderly 
patients, required intubation and CPPV. Two 
of these patients were considered to have second- 
ary bacterial infection and required CPPV 24 h 
after admission after failing to respond to 
initial CPAP therapy. The one elderly patient, 
who failed to respond to CPAP therapy and 
required CPPV, was complicated by early onset 
nosocomial pneumonia. The other patients all 
responded well to ventilatory support with 
CPAP by face mask (eight patients), and three 
patients with face mask oxygen only; this 
improved oxygenation in all cases. The patients 
were monitored continuously using pulse oxi- 
metry, and in all patients, temporary discontinu- 
ation of oxygen at the peak of illness led to 
desaturation. It was, therefore, necessary to 
maintain oxygen therapy at all times, particu- 
larly at meal times, when nasal prong oxygen 
therapy was given. The average duration of 
CPAP was 3.25 f 2.19 days and CPPV 7.X f 7.04 
days. One patient on CPAP developed significant 
atelectasis that responded to fibre-optic bron- 
choscopy and chest physiotherapy. One 
patient developed axillary vein thrombosis 
which responded to heparinization. All patients 
survived. 
Discussion 
In the authors’ community, chickenpox pneumo- 
nia in adults most commonly affects young 
females with young families, probably because of 
the likelihood of exposure. They usually present 
with a high fever, ill and toxic, with a dry 
cough, marked tachypnoea, and are usually very 
hypoxaemic; provided that secondary bacterial 
infection is prevented, recovery should occur 
within a few days. The severe hypoxaemia 
responds well to CPAP by face mask, which is 
the ideal form of therapy because it avoids 
intubation with its attendant increased risk of 
pulmonary infection. Although varicella pneu- 
monia is said to have a high mortality, there 
were no deaths in the present series of patients, 
and this emphasizes the importance of recogniz- 
ing the severity of the resultant hypoxaemia and 
providing appropriate early intensive care and 
ventilatory support with PEEP (9,12). If oxygen 
therapy has been indicated, it should not be 
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discontinued until it is certain that oxygenation 
is adequate. 
The use of acyclovir for varicella remains 
controversial. In two large prospective trials in 
children aged 2-18 years who were given oral 
acyclovir (20 mg kg - ’ to a maximum of 800 mg 
6 hourly) starting within 24 h of rash onset, the 
duration of disease was reduced to a median of 
l-2 days (13,14). Chickenpox is a disease that 
usually only lasts 7 days, and is seldom compli- 
cated in children, and this, coupled with the fact 
that acyclovir is expensive and unlikely to influ- 
ence the transmission of varicella, has brought 
about the recommendation that acyclovir should 
not be used routinely in uncomplicated varicella 
(15). Serious complications of varicella are, how- 
ever, so rare that these controlled trials would 
have insufficient power to detect any effect on 
the incidence of these complications. There is, 
however, a place for acyclovir therapy both in 
immunocompromised individuals and adults 
where varicella is a much more severe disease 
with an increased likelihood of pneumonia. 
Anecdotal reports have not shown any effect on 
mortality, which may be attributed to a delay in 
initiating therapy (7). In the study group of 15 
patients, the average time of onset of illness to 
the administration of acyclovir therapy was as 
long as 6 days, but, nevertheless, there were no 
deaths. 
There is thought to be a 20-fold increase of 
varicella pneumonia in pregnancy, with an 
associated increase in mortality to both the 
infant and mother. Previous studies have 
reported mortalities of as high as 45%; however, 
a recent review of over 21 cases reported in the 
English literature, where acyclovir was used 
in pregnancy, found a mortality of only 14%. 
Reports in other languages would support this 
reduced mortality since the introduction of 
acyclovir (10). Reviews of small series of patients 
in whom acyclovir has been used, suggest that 
the mortality should not be much greater than 
10% even if pregnant patients are considered 
(7,8). The use of acyclovir in pregnancy appears 
safe during the latter trimesters, and no fetal 
abnormalities were seen in 77 cases where acy- 
clovir was used in the first trimester (10). Vari- 
cella infection in the first trimester may itself 
increase the incidence of fetal abnormalities, 
and embryopathy has been shown to occur in 
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2.2% of cases. Propliylactic varicella hyper- 
immune globulin should be considered in indi- 
viduals who have not had the disease and who 
have been exposed, or alternatively varicella 
vaccine may reduce this risk in unexposed indi- 
viduals when given before pregnancy (15,17,1$). 
The use of CPAP by face mask for ventilatory 
support in varicella pneumonia has been recom- 
mended in a number of case reports, and the 
authors would endorse this form of respiratory 
support because it significantly reduces the risk 
of secondary infection (19). Although this has 
not been confirmed in patients with other types 
of pneumonia, it has been found useful in a small 
number of cases when the patient’s respiratory 
failure falls short of the requirement for intuba- 
tion and CPPV (20). In a recent report, however, 
it was found to be suitable for only 5% of cases 
requiring ventilatory support (20). Mask CPAP 
has, however; been clearly shown to reduce 
complications and infection in other causes of 
respiratory failure, particularly when secondary 
to chest trauma (21). 
This study suggests that intensive care admis- 
sion with the early administration of acyclovir, 
coupled with recognition of the severity of 
hypoxaemia that results from varicella pneumo- 
nia, which can be reversed with PEEP and 
particularly CPAP by mask; should reduce the 
mortality of severe varicella pneumonia. 
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